This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its unique structure makes it a valuable intermediate for creating compounds that target central nervous system disorders, such as depression, anxiety, and schizophrenia. Researchers leverage its spirocyclic indole framework to design molecules with enhanced binding affinity and selectivity for specific receptors, such as serotonin or dopamine receptors. Additionally, it has shown potential in the development of drugs for neurodegenerative diseases, including Alzheimer's and Parkinson's, due to its ability to modulate key pathways involved in neuronal function. Its hydrochloride form improves solubility, facilitating its use in various experimental and formulation processes.